✦ LIBER ✦

Second-line chemotherapy with mitomycin-C and 5-fluorouracil in the treatment of refractory metastatic cancer of the urinary bladder

✍ Scribed by T. Otto; S. Krege; B. Otto; M. Goepel; H. Rübben

Book ID: 105812161
Publisher: Springer
Year: 1997
Tongue: German
Weight: 215 KB
Volume: 36
Category: Article
ISSN: 0340-2592
DOI: 10.1007/s001200050098

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-fluorouracil, adriamycin, and mitomyci

5-fluorouracil, adriamycin, and mitomycin-c (fam) combination chemotherapy in the treatment of advanced gastric cancer

✍ John S. Macdonald; Paul V. Woolley; Tariyln Smythe; Winston Ueno; Daniel Hoth; P 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 2 views

Mitomycin C, methyl-CCNU and 5-fluoroura

Mitomycin C, methyl-CCNU and 5-fluorouracil in the treatment of metastatic colorectal carcinoma

✍ Philip D. Bonomi; Govind Chandra; Arthur H. Rossof; David Klaassen 📂 Article 📅 1980 🏛 Springer 🌐 English ⚖ 352 KB

Mitomycin c in the treatment of metastat

Mitomycin c in the treatment of metastatic transitional cell carcinoma of urinary bladder

✍ K. Early; E. G. Elias; A. Mittelman; D. Albert; G. P. Murphy 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

Mitomycin C was administered t o 21 patients with metastatic transitional cell carcinoma of the urinary bladder. O f these, 19 patients were evaluable. Objective response occurred in f o u r patients, or 21 %. Hemopoietic depression was common and was dose related. Nephrotoxicity related t o the dr

Mitomycin C is an inactive drug in the t

Mitomycin C is an inactive drug in the third-line treatment of hormone and chemotherapy refractory breast cancer

✍ Dees, Ad; Verweij, Jaap; van Putten, Wim L.J.; Stoter, Gerrit 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 488 KB

Second-line combination chemotherapy wit

Second-line combination chemotherapy with docetaxel and nedaplatin for metastatic or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus cisplatin

✍ Ryohei Kawabata; Hiroshi Imamura; Tomono Kishimoto; Shinji Kitamura; Yoshimi Hac 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 205 KB

A combination therapy with mitomycin c,

A combination therapy with mitomycin c, etoposide, doxifluridine and medroxyprogesterone acetate as second line therapy for advanced breast cancer refractory to combination chemotherapy of cyclophosphamide, doxorubicin and 5 fluorouracil

✍ Katsumasa Kuroi; Akihiko Osaki; Hiroyuki Kawami; Shigeru Murakami; Tetsuya Toge 📂 Article 📅 1997 🏛 Springer Japan 🌐 English ⚖ 374 KB